Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives
Open accessThe DOI matches its Crossref record; 220 of the 232 references it cites were found in a registry or an index.
Abstract
Background: Cannabis is the most widely used illicit substance worldwide, and legalization for recreational and medical purposes has substantially increased its availability and use in the United States.Objectives: Decades of research have suggested that recreational cannabis use confers risk for cognitive impairment across various domains, and structural and functional differences in the brain have been linked to early and heavy cannabis use.Methods: With substantial evidence for the role of the endocannabinoid system in neural development and understanding that brain development continues into early adulthood, the rising use of cannabis in adolescents and young adults raises major concerns. Yet some formulations of cannabinoid compounds are FDA-approved for medical uses, including applications in children.Results: Potential effects on the trajectory of brain morphology and cognition, therefore, should be considered. The goal of this review is to update and consolidate relevant findings in order to inform attitudes and public policy regarding the recreational and medical use of cannabis and cannabinoid compounds.Conclusions: The findings point to considerations for age limits and guidelines for use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such heavy cannabis use is concerning, as it has been linked to impaired thinking, slower reaction times, and poor coordination, all of which can undermine safe driving [32].”
From Road safety threats and occupational health risk associated with psychoactive substance use and dependence risk among commercial drivers: WHO ASSIST evidence from Ghana (2026) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The design was appropriate because it allowed data to be collected at a single point in time to assess the types, prevalence, levels of dependence, associated factors, and reasons for psychoactive substance use among commercial drivers [32].”
From Road safety threats and occupational health risk associated with psychoactive substance use and dependence risk among commercial drivers: WHO ASSIST evidence from Ghana (2026) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
Moreno‐Alcázar, A., Gonzalvo, B., Canales-Rodríguez, E. J., Blanco, L., Bachiller, D., Romaguera, A., Monté, G. C., Roncero, C., McKenna, P. J., & Pomarol‐Clotet, E. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00175 · Cited by 38
Mechanisms Underlying the Link between Cannabis Use and Prospective Memory
Cuttler, C., McLaughlin, R. J., & Graf, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036820 · Cited by 36
Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco
Tsui, J. I., Vittinghoff, E., Hahn, J. A., Evans, J. L., Davidson, P. J., & Page, K. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.05.022 · Cited by 34
Theunissen, E. L., Heckman, P. R. A., Perna, E. B. D. S. F., Kuypers, K. P. C., Sambeth, A., Blokland, A., Prickaerts, J., Toennes, S. W., & Ramaekers, J. G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3667-2 · Cited by 33
The effect of interactions between genetics and cannabis use on neurocognition. A review
Cosker, E., Schwitzer, T., Ramoz, N., Ligier, F., Lalanne, L., Gorwood, P. A. P. M., Schwan, R., & Laprévote, V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.024 · Cited by 32
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults
Kelly, C. A. M., Castellanos, F. X., Tomaselli, O., Lisdahl, K. M., Tamm, L., Jernigan, T. L., Newman, E. R., Epstein, J. N., Molina, B. S. G., Greenhill, L. L., et al. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.09.012 · Cited by 31
Gillespie, N. A., Neale, M. C., Bates, T. C., Eyler, L. T., Fennema‐Notestine, C., Vassileva, J., Lyons, M. J., Prom‐Wormley, E. C., McMahon, K. L., Thompson, P. M., et al. (2018) · Addiction · doi:10.1111/add.14252 · Cited by 31
Rogers, R. D., Wakeley, J., Robson, P. J., Bhagwagar, Z., & Mäkelä, P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301175 · Cited by 29
Bourque, J., Mendrek, A., Durand, M., Lakis, N., Lipp, O., Stip, É., Lalonde, P., Grignon, S., & Potvin, S. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.05.012 · Cited by 29
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans
Ranganathan, M., Carbuto, M., Braley, G., Elander, J., Perry, E., Pittman, B., Radhakrishnan, R., Sewell, R. A., & D'Souza, D. C. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001830 · Cited by 27
Suicide in paradise: aftermath of the Bali bombings
Suryani, L. K., Page, A., Lesmana, C. B. J., Jennaway, M., Basudewa, I. D. G., & Taylor, R. J. (2008) · Psychological Medicine · doi:10.1017/s0033291708004893 · Cited by 22
Papatheodorou, S., Buettner, H., Rice, M. B., & Mittleman, M. A. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.12.033 · Cited by 21
Latorre, J. G., & Schmidt, E. B. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0627-3 · Cited by 18
Gu, B. (2017) · Global Drugs and Therapeutics · doi:10.15761/gdt.1000134 · Cited by 16
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Ciccone, C. D. (2016) · Physical Therapy · doi:10.2522/ptj.20160367 · Cited by 15
What adolescents enrolled in genomic addiction research want to know about conflicts of interest
Coors, M. E., Raymond, K. M., McWilliams, S. K., Hopfer, C. J., & Mikulich‐Gilbertson, S. K. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.004 · Cited by 12
Pharmacologic Treatment of Intractable Epilepsy in Children: A Syndrome-Based Approach
Hussain, S. A., & Sankar, R. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.06.003 · Cited by 11
Dornbush, R. L., & Freedman, A. M. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb49877.x · Cited by 11
Cannabis, cannabidiol, and epilepsies: The truth is somewhere in the middle
Sirven, J. I. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.09.006 · Cited by 9
Mokrysz, C., & Freeman, T. P. (2018) · Addiction · doi:10.1111/add.14055 · Cited by 6
Research works printed but not linked: 1
- Schmetzer AD. Book review: cannabis and cognitive functioning, by Nadia Solowij. Ann Clin Psychiatry. 2000; 12: 254– 57. doi: 10.1023/A:1009051030174. · doi:10.1023/a:1009051030174
Cited by
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
Leinen, Z. J., Mohan, R., Premadasa, L. S., Acharya, A., Mohan, M., & Byrareddy, S. N. (2023) · Biomedicines · doi:10.3390/biomedicines11102630 · Cited by 150
One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory
Schuster, R. M., Gilman, J. M., Schoenfeld, D., Evenden, J. L., Hareli, M., Ulysse, C. A., Nip, E., Hanly, A. M., Zhang, H., & Evins, A. E. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11977 · Cited by 78
E-cigarettes may serve as a gateway to conventional cigarettes and other addictive drugs
Chen, G. L., Rahman, S., & Lutfy, K. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11345 · Cited by 59
Use of Medical Cannabis to Treat Traumatic Brain Injury
Hergert, D. C., Robertson‐Benta, C. R., Sicard, V., Schwotzer, D., Hutchison, K. E., Covey, D. P., Quinn, D. K., Sadek, J. R., McDonald, J. D., & Mayer, A. R. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7148 · Cited by 47
Metadata
- Authors
- Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D.
- Affiliations
- University of Oregon (US)
- University of California, Los Angeles (US)
- Corresponding author
- London, Edythe D.
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2019-07-31
- Volume
- 45
- Issue
- 6
- Pages
- 563-579
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- PMC
- PMC7027431
- OpenAlex
- W2965445678
- Cited by
- 144
- References
- 232
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 22 · 2022: 15 · 2021: 16 · 2020: 10 · 2019: 3
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Drug and Alcohol Abuse (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Drug Abuse (K01DA034728, T32DA024635)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- cannabis, medical cannabis, recreational cannabis, cognitive impairment, brain structure, brain function, endocannabinoid system, adolescent cannabis use, brain development, cannabis policy
- MeSH terms
- Autism Spectrum Disorder, Age Factors, Attention Deficit Disorder with Hyperactivity, Brain, Cannabidiol, Cognition, Epilepsies, Myoclonic, Humans, Infant, Organ Size, Spasms, Infantile, Dronabinol, Endocannabinoids, Medical Marijuana, Lennox Gastaut Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.